Imricor Medical Systems Inc (IMR) - Total Liabilities
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has total liabilities worth AU$34.26 Million AUD (≈ $24.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Imricor Medical Systems Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Imricor Medical Systems Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Imricor Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see IMR current and non-current assets.
Imricor Medical Systems Inc Competitors by Total Liabilities
The table below lists competitors of Imricor Medical Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
|
China | CN¥2.43 Billion |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
|
China | CN¥1.19 Billion |
|
Zhejiang Giuseppe Garment Co Ltd
SHE:002687
|
China | CN¥473.05 Million |
|
WHA UTILITIES AND PO
BK:WHAUP-R
|
Thailand | ฿17.49 Billion |
|
Jiangsu Baoli Asphalt
SHE:300135
|
China | CN¥586.32 Million |
|
Jiangsu WELLE Environmental Co Ltd
SHE:300190
|
China | CN¥4.41 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥222.08 Million |
|
Icon Offshore Bhd
KLSE:5255
|
Malaysia | RM525.08 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Imricor Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See IMR equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Imricor Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Imricor Medical Systems Inc (2016–2025)
The table below shows the annual total liabilities of Imricor Medical Systems Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AU$34.26 Million ≈ $24.24 Million |
+18.12% |
| 2024-12-31 | AU$29.00 Million ≈ $20.52 Million |
+69.98% |
| 2023-12-31 | AU$17.06 Million ≈ $12.07 Million |
+175.61% |
| 2022-12-31 | AU$6.19 Million ≈ $4.38 Million |
+38.68% |
| 2021-12-31 | AU$4.46 Million ≈ $3.16 Million |
-6.09% |
| 2020-12-31 | AU$4.75 Million ≈ $3.36 Million |
+36.27% |
| 2019-12-31 | AU$3.49 Million ≈ $2.47 Million |
+34.78% |
| 2018-12-31 | AU$2.59 Million ≈ $1.83 Million |
-68.63% |
| 2017-12-31 | AU$8.25 Million ≈ $5.84 Million |
+10.08% |
| 2016-12-31 | AU$7.50 Million ≈ $5.30 Million |
-- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more